Effects of neocarzinostatin-chimeric Fab conjugates on pancreatic cancer growth
Author Information
Author(s): E Otsuji, T Yamaguchi, H Tsuruta, Y Yata, H Nishi, K Okamoto, K Taniguchi, M Kato, T Kotani, K Kitamura, T Takahashi
Primary Institution: Kyoto Prefectural University of Medicine
Hypothesis
Can neocarzinostatin conjugated to chimeric Fab fragments effectively inhibit the growth of human pancreatic carcinoma?
Conclusion
ChA7Fab-NCS significantly suppressed the growth of pancreatic cancer in a mouse model.
Supporting Evidence
- ChA7Fab-NCS showed a greater anti-tumor effect than A7-NCS or NCS alone.
- Tumor growth was completely suppressed in the chA7Fab-NCS treated group.
- ChA7Fab-NCS accumulated more rapidly in tumors compared to A7-NCS.
Takeaway
This study shows that a special drug combined with an antibody can stop pancreatic cancer from growing in mice.
Methodology
The study used a nude mouse model to test the anti-tumor effects of chA7Fab-NCS compared to A7-NCS and NCS alone.
Limitations
The study was conducted in a mouse model, which may not fully represent human responses.
Participant Demographics
Nude mice, specifically 8-week-old male BALB/C mice.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website